Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
- Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Brazil +19 more
- Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Exocrine Pancreatic Cancer · Carcinoma, Squamous Cell of Head and Neck
United States, Canada, France, Germany, Italy +2 more
- A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid TumorsActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Breast Neoplasms · Gastroesophageal Junction Adenocarcinoma · HER2 Low Breast Neoplasms · HER2 Positive Breast Neoplasms
United States, Australia, Canada, Germany, Italy +5 more
Sponsor: Pfizer
Advanced/Metastatic Non-Small Cell Lung Cancer · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Cancer
United States, China, France, Germany, Italy +4 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Cervical Cancer
United States, Belgium, Czechia, Denmark, Ireland +5 more
Sponsor: Pfizer
Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Austria, Belgium +26 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung · Stomach Neoplasms · Pancreatic Ductal Adenocarcinoma
United States, Canada, China, France, Israel +5 more
Sponsor: Pfizer
Healthy Participants · Atopic Dermatitis
United States
- A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2 Positive Breast Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
Sponsor: Pfizer
Advanced Breast Cancer · Metastatic Breast Cancer (HR+/ HER2-) · Colorectal Cancer · Metastatic Colorectal Adenocarcinoma
United States
- Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatment of Duchenne Muscular DystrophyActive Not Recruiting
Sponsor: Pfizer
Duchenne Muscular Dystrophy
United States, Australia, Belgium, Canada, France +10 more
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Squamous Cell Carcinoma of the Head and Neck · Esophageal Squamous Cell Carcinoma · Triple Negative Breast Neoplasms
United States, Belgium, Canada, China, France +6 more
- Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLActive Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Diffuse Large B-cell Lymphoma
United States, Australia, Belgium, Canada, Czechia +9 more
- A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2Active Not Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung · Ovarian Neoplasms · Endometrial Neoplasms · Head and Neck Neoplasms
United States, Australia, Canada, Italy, South Korea +2 more
- A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.Active Not Recruiting
Sponsor: Pfizer
Carcinoma, Pancreatic Ductal · Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung
United States, Puerto Rico
- A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid TumorsRecruiting
Sponsor: Pfizer
Advanced/Metastatic Solid Tumors · Bladder Cancer · Urothelial Carcinoma · Advanced Non-Small Cell Lung Cancer
United States, Canada, Puerto Rico, Spain, United Kingdom
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Colorectal Neoplasms
United States, Argentina, Australia, Austria, Belgium +20 more
- A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Recruiting
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Argentina, Australia, Belgium, Canada +7 more
Sponsor: Pfizer
Healthy Subjects
United States
Sponsor: Yale University
Prostate Cancer
United States
Sponsor: Massachusetts General Hospital
Metastatic Malignant Neoplasm to Brain · Recurrent Brain Metastases · Progressive Brain Metastases
United States
Sponsor: St. Jude Children's Research Hospital
Osteosarcoma
United States
Sponsor: The University of Texas Health Science Center, Houston
Cluster Headache
United States
- The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerActive Not Recruiting
Sponsor: Adrienne G. Waks
Breast Cancer
United States